Page last updated: 2024-09-03
bq 610 and interleukin-8
bq 610 has been researched along with interleukin-8 in 1 studies
Compound Research Comparison
| Studies (bq 610) | Trials (bq 610) | Recent Studies (post-2010) (bq 610) | Studies (interleukin-8) | Trials (interleukin-8) | Recent Studies (post-2010) (interleukin-8) |
|---|---|---|---|---|---|
| 124 | 1 | 3 | 23,523 | 1,167 | 9,990 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chen, M; Chen, P; Hofman, FM; Zidovetzki, R | 1 |
Other Studies
1 other study(ies) available for bq 610 and interleukin-8
| Article | Year |
|---|---|
Endothelin-1-induced interleukin-8 production in human brain-derived endothelial cells is mediated by the protein kinase C and protein tyrosine kinase pathways.
Topics: Antihypertensive Agents; Brain; Cells, Cultured; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Humans; Interleukin-8; Oligopeptides; Piperidines; Receptors, Endothelin; Signal Transduction | 1999 |